carteolol has been researched along with betaxolol in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (14.71) | 18.7374 |
1990's | 9 (26.47) | 18.2507 |
2000's | 15 (44.12) | 29.6817 |
2010's | 2 (5.88) | 24.3611 |
2020's | 3 (8.82) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Hugues, FC; Le Jeunne, C; Munera, Y | 1 |
Collignon-Brach, J | 1 |
James, IM | 1 |
Pillunat, LE; Stodtmeister, R | 1 |
Zimmerman, TJ | 1 |
Becker, EJ; Chen, Z; DeSantis, L; Hester, RK; McLaughlin, M | 1 |
Frishman, WH; Fuksbrumer, MS; Tannenbaum, M | 1 |
Cassels-Brown, A; Diggory, P; Fernandez, C | 1 |
Hong, SJ; Wang, HZ; Wu, KY | 2 |
Araie, M; Nagahara, M; Tamaki, Y; Tomidokoro, A; Tomita, K | 1 |
Hayashi, E; Hayashi-Morimoto, R; Ishikawa, H; Sato, Y; Yoshitomi, T | 1 |
Melena, J; Osborne, NN; Wood, JP | 1 |
Chidlow, G; Melena, J; Osborne, NN | 1 |
Kijlstra, A; Mulder, M; van Beek, LM; van Haeringen, NJ | 1 |
Iga, T; Ito, K; Ohtani, H; Sawada, Y; Takayanagi, R; Tsuchiya, K; Yamada, Y | 1 |
Barnett, MF; Haybittle, J; Parker, V; Watson, PG | 1 |
Belcaro, GV; Cesarone, MR; De Sanctis, MT; Incandela, L; Laurora, G; Minicucci, R; Steigerwalt, RD | 1 |
Ishibashi, Y; Muto, T; Roy, S; Sato, T | 1 |
Clark, JI; Martin, RW; Vaezy, S; Zderic, V | 1 |
Fong, JC; Hong, SJ; Wang, HZ; Wu, KY | 1 |
Baudouin, C; Blondin, C; Cholley, B; Haeffner-Cavaillon, N; Hamard, P | 1 |
Ignat, F | 1 |
Ikeda, Y; Ishibashi, T; Kinoshita, S; Mori, K; Nakajima, N; Naruse, S | 1 |
Jia, L; Li, Z; Wu, J; Xiao, X | 1 |
Fůs, M; Lešták, J; Marešová, K; Weissová, I | 1 |
Barbeau, M; Beauchemin, C; Cui, AX; Harasymowycz, P; Jobin-Gervais, K; Lachaine, J; Mathurin, K; Royer, C | 1 |
Jedlowski, MF; Jedlowski, PM | 1 |
5 review(s) available for carteolol and betaxolol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
Pharmacologic effects of beta-blocking agents used in the management of glaucoma.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Propanolamines; Solubility; Timolol | 1989 |
Topical ophthalmic beta blockers: a comparative review.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Carteolol; Drug Tolerance; Glaucoma; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Ophthalmic Solutions; Timolol | 1993 |
Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Levobunolol; Metipranolol; Ocular Hypertension; Timolol | 1994 |
Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis.
Topics: Amides; Antihypertensive Agents; Bayes Theorem; Betaxolol; Bimatoprost; Brimonidine Tartrate; Carteolol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Network Meta-Analysis; Ocular Hypertension; Prostaglandins A; Prostaglandins F, Synthetic; Timolol; Travoprost | 2022 |
6 trial(s) available for carteolol and betaxolol
Article | Year |
---|---|
Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition.
Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Carteolol; Female; Heart Rate; Humans; Isoproterenol; Male; Muscle, Smooth, Vascular; Myocardium; Ophthalmic Solutions; Randomized Controlled Trials as Topic; Timolol | 1990 |
Early visual field changes with beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Drug Evaluation, Preclinical; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Propanolamines; Timolol; Visual Fields | 1989 |
Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Airway Resistance; Betaxolol; Blood Pressure; Carteolol; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Pulse; Spirometry; Sympathomimetics; Timolol | 1996 |
Effects of topical adrenergic agents on tissue circulation in rabbit and human optic nerve head evaluated with laser speckle tissue circulation analyzer.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Animals; Betaxolol; Blood Circulation; Blood Flow Velocity; Blood Pressure; Carteolol; Double-Blind Method; Hemorheology; Humans; Intraocular Pressure; Ophthalmic Solutions; Optic Disk; Propanolamines; Quinazolines; Rabbits | 1997 |
A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Carteolol; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Linear Models; Male; Prospective Studies; Survival Analysis; Timolol; Trabeculectomy; Treatment Outcome; Visual Fields | 2001 |
Effects of switching from topical beta-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Betaxolol; Carteolol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Propanolamines; Prospective Studies; Prostaglandins F, Synthetic; Time Factors | 2008 |
23 other study(ies) available for carteolol and betaxolol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs.
Topics: Acetazolamide; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Optic Disk; Pilocarpine; Propanolamines; Timolol | 1989 |
New topical beta-blockers for glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Metipranolol; Propanolamines | 1987 |
The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery.
Topics: Animals; Arteries; Betaxolol; Calcium; Carteolol; Ciliary Body; Iliac Artery; Muscle, Smooth, Vascular; Nitroprusside; Rabbits; Swine; Timolol; Vasoconstriction | 1994 |
Effects of pilocarpine and other antiglaucoma drugs on cultured human Tenon's fibroblast cells.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Cell Division; Cells, Cultured; Eye; Fibroblasts; Glaucoma; Humans; Levobunolol; Muscarinic Agonists; Pilocarpine; Thymidine; Timolol | 1997 |
Effects of beta antagonists on mechanical properties in rabbit ciliary artery.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Carteolol; Cholinergic Agonists; Ciliary Arteries; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoproterenol; Male; Muscle, Smooth, Vascular; Phenylephrine; Rabbits; Receptors, Adrenergic, alpha-1; Timolol; Vasoconstriction | 1999 |
Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels.
Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Binding, Competitive; Calcium Channels; Carteolol; Cerebral Cortex; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Membranes; Nitrendipine; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Stereoisomerism; Timolol; Tritium | 1999 |
Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Batrachotoxins; Betaxolol; Binding, Competitive; Carteolol; Cerebral Cortex; Dose-Response Relationship, Drug; Kinetics; Levobunolol; Membranes; Propranolol; Rats; Rats, Wistar; Saxitoxin; Sodium; Sodium Channels; Sodium Radioisotopes; Synaptosomes; Timolol; Tritium | 2000 |
Topical ophthalmic beta blockers may cause release of histamine through cytotoxic effects on inflammatory cells.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Basophils; Betaxolol; Carteolol; Cells, Cultured; Dose-Response Relationship, Drug; Histamine Release; Humans; L-Lactate Dehydrogenase; Leukocytes; Metipranolol; Timolol | 2000 |
Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Cardiovascular Diseases; Carteolol; Exercise; Forced Expiratory Volume; Heart; Heart Rate; Humans; Lung; Ophthalmic Solutions; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Respiration Disorders; Retrospective Studies; Timolol | 2001 |
Ocular and retrobulbar blood flow in ocular hypertensives treated with topical timolol, betaxolol and carteolol.
Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Betaxolol; Blood Flow Velocity; Carteolol; Ciliary Arteries; Humans; Middle Aged; Ocular Hypertension; Ophthalmic Artery; Retinal Artery; Timolol | 2001 |
Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Blood Flow Velocity; Blood Pressure; Carteolol; Choroid; Ciliary Body; Eye; Heart Rate; Intraocular Pressure; Rabbits; Random Allocation; Regional Blood Flow; Retinal Vessels; Timolol; Vascular Resistance | 2001 |
Ocular drug delivery using 20-kHz ultrasound.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Carteolol; Cornea; Drug Delivery Systems; Epithelium; Models, Animal; Permeability; Rabbits; Timolol; Ultrasonics | 2002 |
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.
Topics: Animals; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Calcium; Carteolol; Cell Death; Dose-Response Relationship, Drug; Epinephrine; Glaucoma; Glutamic Acid; Latanoprost; Mice; Neuroblastoma; Neurons; Neuroprotective Agents; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Tumor Cells, Cultured | 2003 |
In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system.
Topics: Adrenergic beta-Antagonists; Benzalkonium Compounds; Betaxolol; Carteolol; Complement System Proteins; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Timolol | 2003 |
[Neuroprotection and vasoprotection in glaucoma].
Topics: Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Carteolol; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Neuroprotective Agents; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Treatment Outcome | 2004 |
Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells.
Topics: Animals; Betaxolol; Carteolol; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Corneal; Glaucoma; L-Lactate Dehydrogenase; Levobunolol; Pilocarpine; Timolol | 2007 |
Enantioseparation of chiral β-blockers using polynorepinephrine-coated nanoparticles and chiral capillary electrophoresis.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Electrophoresis, Capillary; Equipment Design; Humans; Limit of Detection; Magnetics; Magnetite Nanoparticles; Metoprolol; Norepinephrine; Solid Phase Microextraction; Stereoisomerism | 2019 |
Betaxolol, Brimonidin and Carteolol in the Therapy of Normal-Tension Glaucoma.
Topics: Betaxolol; Carteolol; Evoked Potentials, Visual; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged | 2020 |
Topical ophthalmic beta-blockers are associated with ocular pseudopemphigoid: A pharmacovigilance study of antiglaucoma medications utilising the FDA adverse event reporting system.
Topics: Adrenergic beta-Antagonists; Antiglaucoma Agents; Betaxolol; Carteolol; Humans; Irritants; Ophthalmic Solutions; Pharmacovigilance; Preservatives, Pharmaceutical | 2022 |